Valuation (9%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.95 | -20.30 |
| PEG Ratio (TTM) | -0.13 | -5.71 |
| P/S Ratio (TTM) | 642.66 | 50.88 |
| P/B Ratio (TTM) | 4.68 | 29.28 |
| P/FCF Ratio (TTM) | -1.97 | -8.95 |
| Price to 5YR AVG Earnings Ratio | -1.56 | -6.52 |
| Price to 5YR AVG FCF Ratio | -4.06 | -14.78 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -148.74% | -18.85% |
| ROE (TTM) | -203.91% | 25.35% |
| Net Profit Margin (TTM) | -32,973.66% | -827.80% |
| ROIC 5YR AVG | -436.50% | -26.10% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.59% | -139.36% | -88.33% |
| Revenue | -25.00% | 180.54% | 93.18% |
| Net Income | -10.76% | -149.92% | -100.60% |
| Cash Flow | -18.03% | -168.67% | -110.65% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.99 | 6.09 |
| Quick Ratio (TTM) | 2.99 | 5.87 |
| D/E Ratio (TTM) | 0.06 | 1.00 |
| Interest Coverage (TTM) | N/A | -9.57 |
| Piotroski F-Score | 2 | 4 |
| Altman Z-Score | N/A | 13.84 |
| LTL to 5YR AVG FCF | -0.07 | 0.07 |
| Shares Outstanding Growth 5YR AVG | 22.93% | 44.11% |